TIS21 /BTG2/PC3 as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule

Review

Abstract

TIS21/BTG2/PC3, orthologs of mouse, human and rat, respectively, is initially identified as one of the early growth response genes and induced by various stimulations. TIS21 belongs to antiproliferative (APRO) gene family containing the BTG-Box A (Y50–N71) and BTG-Box B (L97–E115), which are highly conserved among various species. On the other hand, it has lately been found that the expression of TIS21 is constitutive and high in thymus, lung alveolar epithelium, proximal tubule of kidney and basal cell layer of prostate acini. Potential roles of TIS21 have been suggested as transcriptional co-regulator, differentiation and antiapoptotic factor in neurogenesis, key mediator of the stage-specific expansion of thymocyte and negative regulator of hematopoietic progenitor expansion, and tumor suppressor gene in both mouse and human. In addition, as pan-cell cycle regulator TIS21 induces G1/S arrest by pRB dependently and pRB independently and G2/M arrest and cell death in the p53 null tumor cells, and regulates the development of vertebrate patterning in mouse, paraxial mesoderm development in zebrafish, and notochord development in Xenopus. It has been known that the expression of TIS21 depends on the induction of wt p53 when cells are damaged, however, it can also be upregulated p53 independently by the activation of PKC-δ pathway in tumor cells. The characteristic roles of TIS21 are discussed in the present review: (1) TIS21 inhibits early phase of carcinogenesis in its high expressers such as kidney, prostate, breast and thymus: Loss of constitutive and high expression of TIS21 was observed in the precancerous lesions as well as tumor tissues. As an endogenous cell death molecule, TIS21 may be involved in translocation of Pin-1 to cytoplasm. Pin-1 subsequently interacts with Serine147 residue in TIS21 protein, resulting in mitochondrial depolarization. (2) TIS21 regulates transition of cell cycle at G1/S and G2/M phases in cancer cells with inactive pRB and/or p53, as well as in normal cells by regulating pRB/p16INK4a pathway. The latter has already been well elucidated; TIS21 inhibits the expression of cyclin D1, thus resulting in the arrest of cells at G1/S phase by pRB and p53 dependent manner. On the other hand, TIS21 inhibits degradations of cyclin A and cyclin B1 at G2/M phase, and directly binds to Cdc2, resulting in the failure of mitotic exit and then increasing the tumor cell death, when stimulated by high concentration of EGF. Therefore, TIS21 can be suggested as a pan-cell cycle modulator. (3) TIS21 regulates embryo development by activating BMP signal through interaction with Smad 1 and Smad 8, thereby regulating vertebral patterning in mice. It is also involved in notochord development in Xenopus and paraxial mesoderm development in zebrafish. Based on the previous report that the expression of TIS21 is involved in the induction of senescence after chemotherapy of cancer cells, which can be a mechanism to resist carcinogenesis, TIS21/BTG2/PC3, the endogenous cell death molecule and pan-cell cycle regulator, might be a link between cellular senescence and carcinogenesis.

Keywords

TIS21/BTG2/PC3 Antiproliferative gene G1/S and G2M arrest p53 independent cell cycle regulation Tumor suppressor gene 

Notes

Acknowledgement

This work was supported by a grant Korea Health 21 R&D Project, 02-PJ10-PG8-EC01-0028. Author deeply appreciates Profs. Emeritus Woon Ki Paik and Sangduk Kim for their careful reading and encouragement for this article.

References

  1. Alevizopoulos K, Vlach J, Hennecke S, Amati B (1997) Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J 16:5322–5333PubMedCrossRefGoogle Scholar
  2. Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L (2003) The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63:6244–6251PubMedGoogle Scholar
  3. Berthet C, Guehenneux F, Revol V, Samarut C, Lukaszewicz A, Dehay C, Dumontet C, Magaud JP, Rouault JP (2002) Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects. Genes Cells 7:29–39PubMedCrossRefGoogle Scholar
  4. Bradbury A, Possenti R, Shooter EM, Tirone F (1991) Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci USA 88:3353–3357PubMedCrossRefGoogle Scholar
  5. Calegari F, Haubensak W, Yang D, Huttner WB, Buchholz F (2002) Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc Natl Acad Sci USA 99:14236–14240 PubMedCrossRefGoogle Scholar
  6. Calegari F, Haubensak W, Haffner C, Huttner WB (2005) Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development. J Neurosci 25:6533–6538PubMedCrossRefGoogle Scholar
  7. Canzoniere D, Farioli-Vecchioli S, Conti F, Ciotti MT, Tata AM, Augusti-Tocco G, Mattei E, Lakshmana MK, Krizhanovsky V, Reeves SA, Giovannoni R, Castano F, Servadio A, Ben-Arie N, Tirone F (2004) Dual control of neurogenesis by PC3 through cell cycle inhibition and induction of Math1. J Neurosci 24:3355–3369PubMedCrossRefGoogle Scholar
  8. Corrente G, Guardavaccaro D, Tirone F (2002) PC3 potentiates NGF-induced differentiation and protects neurons from apoptosis. Neuroreport 13:417–422PubMedCrossRefGoogle Scholar
  9. Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi FE, Barnas C, Morel AP, Hainaut P, Magaud JP, Puisieux A (2000) BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog 27:57–64 PubMedCrossRefGoogle Scholar
  10. DePinho RA, Polyak K (2004) Cancer chromosomes in crisis. Nat Genet 36:932–934 PubMedCrossRefGoogle Scholar
  11. Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S, Wang Q, Soussi T, Puisieux A. (2002) The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene 282:207–214PubMedCrossRefGoogle Scholar
  12. Duriez C, Moyret-Lalle C, Falette N, El-Ghissassi F, Puisieux A (2004) BTG2, its family and its tutor. Bull Cancer 91:242–253Google Scholar
  13. el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A (2002) BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 21:6772–6778PubMedCrossRefGoogle Scholar
  14. Elmore LW, Di X, Dumur C, Holt SE, Gewirtz DA (2005) Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Clin Cancer Res 11:2637–2643PubMedCrossRefGoogle Scholar
  15. Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD (2001) Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22:1271–1279 PubMedCrossRefGoogle Scholar
  16. Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR (1991) Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266:14511–14518PubMedGoogle Scholar
  17. Goldschneider D, Million K, Meiller A, Haddada H, Puisieux A, Benard J, May E, Douc-Rasy S (2005) The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells. J Cell Sci 118:1245–1253PubMedCrossRefGoogle Scholar
  18. Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74PubMedCrossRefGoogle Scholar
  19. Greenberg RA (2005) Telomeres, crisis and cancer. Curr Mol Med 5:213–218PubMedCrossRefGoogle Scholar
  20. Guardavaccaro D, Corrente G, Covone F, Micheli L, D’Agnano I, Starace G, Caruso M, Tirone F (2000) Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 20:1797–1815PubMedCrossRefGoogle Scholar
  21. Guehenneux F, Duret L, Callanan MB, Bouhas R, Hayette S, Berthet C, Samarut C, Rimokh R, Birot AM, Wang Q, Magaud JP, Rouault JP (1997) Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11:370–375PubMedCrossRefGoogle Scholar
  22. Haubensak W, Attardo A, Denk W, Huttner WB (2004) Neurons arise in the basal neuroepithelium of the early mammalian telencephalon: a major site of neurogenesis. Proc Natl Acad Sci USA 101:3196–3201PubMedCrossRefGoogle Scholar
  23. Herschman HR (1991) Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60:281–319PubMedCrossRefGoogle Scholar
  24. Hong JW, Ryu MS, Lim IK (2005) Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death. J Biol Chem 280:21256–21263PubMedCrossRefGoogle Scholar
  25. Iacopetti P, Michelini M, Stuckmann I, Oback B, Aaku-Saraste E, Huttner WB (1999) Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division. Proc Natl Acad Sci USA 96:4639–4644PubMedCrossRefGoogle Scholar
  26. Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD, Maheswaran S (2004) Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene 23:8310–8319PubMedCrossRefGoogle Scholar
  27. Konrad MA, Zuniga-Pflucker JC (2005) The BTG/TOB family protein TIS21 regulates stage-specific proliferation of developing thymocytes. Eur J Immunol 35:3030–3042PubMedCrossRefGoogle Scholar
  28. Kosodo Y, Roper K, Haubensak W, Marzesco AM, Corbeil D, Huttner WB (2004) Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. EMBO J 23:2314–2324 PubMedCrossRefGoogle Scholar
  29. Lee MS, Hong I, Lim IK (1996) Expression of TIS21 in the embryonic liver of BALB/c mouse. Ajou Med J 1: 99–104Google Scholar
  30. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422–426PubMedCrossRefGoogle Scholar
  31. Lim IK, Kim NK, Lee MS, Lee SH (1994) Expression of TIS-21 gene during the development of Balb/c mice and the liver regeneration. Korean J Biochem 26: 169–175Google Scholar
  32. Lim IK, Lee MS, Lee SH, Kim NK, Jou I, Seo JS, Park SC (1995) Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol 121:279–284PubMedCrossRefGoogle Scholar
  33. Lim IK, Lee MS, Ryu MS, Park TJ, Fujiki H, Eguchi H, Paik WK (1998a) Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol Carcinog 23:25–35CrossRefGoogle Scholar
  34. Lim IK, Park TJ, Kim S, Lee HW, Paik WK (1998b) Enzymatic methylation of recombinant TIS21 protein-arginine residues. Biochem Mol Biol Int 45:871–878Google Scholar
  35. Lin WJ, Gary JD, Yang MC, Clarke S, Herschman HR (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271:15034–15044PubMedCrossRefGoogle Scholar
  36. Lin WJ, Chang YF, Wang WL, Huang CY (2001) Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1. Biochem J 354:635–643PubMedCrossRefGoogle Scholar
  37. Lu KP, Hanes SD, Hunter T (1996) A human peptidyl–prolyl isomerase essential for regulation of mitosis. Nature 380:544–547PubMedCrossRefGoogle Scholar
  38. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J (1997) Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev 11:1479–1492PubMedCrossRefGoogle Scholar
  39. Matsuda S, Rouault J, Magaud J, Berthet C (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497:67–72PubMedCrossRefGoogle Scholar
  40. Melamed J, Kernizan S, Walden PD (2002) Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell 34:28–32PubMedCrossRefGoogle Scholar
  41. Moran E (1993) Interaction of adenoviral proteins with pRB and p53. FASEB J 7:880–885PubMedGoogle Scholar
  42. Morel AP, Sentis S, Bianchin C, Le Romancer M, Jonard L, Rostan MC, Rimokh R, Corbo L (2003) BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. J Cell Sci 116:2929–2936PubMedCrossRefGoogle Scholar
  43. Oswald J, Steudel C, Salchert K, Joergensen B, Thiede C, Ehninger G, Werner C, Bornhauser M (2005) Gene expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix. Stem Cells 15:(Epub ahead of print) Google Scholar
  44. Park S, Lee YJ, Lee HJ, Seki T, Hong KH, Park J, Beppu H, Lim IK, Yoon JW, Li E, Kim SJ, Oh SP (2004) B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol Cell Biol 24:10256–10262PubMedCrossRefGoogle Scholar
  45. Prevot D, Voeltzel T, Birot AM, Morel AP, Rostan MC, Magaud JP, Corbo L (2000) The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. J Biol Chem 275:147–153PubMedCrossRefGoogle Scholar
  46. Prevot D, Morel AP, Voeltzel T, Rostan MC, Rimokh R, Magaud JP, Corbo L (2001) Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J Biol Chem 276:9640–9648PubMedCrossRefGoogle Scholar
  47. Roninson IB (2002) Tumor senescence as a determinant of drug response in vivo. Drug Resist Updat 5:204–208PubMedCrossRefGoogle Scholar
  48. Roninson IB (2003) Tumor cell senescence in cancer treatment. Cancer Res 63:2705–2715PubMedGoogle Scholar
  49. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A (1996) Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14:482–486PubMedCrossRefGoogle Scholar
  50. Rouault JP, Prevot D, Berthet C, Birot AM, Billaud M, Magaud JP, Corbo L (1998) Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem 273:22563–22569PubMedCrossRefGoogle Scholar
  51. Ryo A, Uemura H, Ishiguro H, Saitoh T, Yamaguchi A, Perrem K, Kubota Y, Lu KP, Aoki I (2005) Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin Cancer Res 11:7523–7531PubMedCrossRefGoogle Scholar
  52. Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E, Lim IK (2004) TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res 299:159–170PubMedCrossRefGoogle Scholar
  53. Sakaguchi T, Kuroiwa A, Takeda H (2001) Expression of zebrafish btg-b, an anti-proliferative cofactor, during early embryogenesis. Mech Dev 104:113–115PubMedCrossRefGoogle Scholar
  54. Seo MS, Lee MS, Lim IK (1999) Expression of rat BTG(3) gene, Rbtg3, is regulated by redox changes. Gene 240:165–173PubMedCrossRefGoogle Scholar
  55. Shay JW, Roninson IB (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919–2933PubMedCrossRefGoogle Scholar
  56. Shay JW, Wright WE (2005) Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26:867–874PubMedCrossRefGoogle Scholar
  57. Struckmann K, Schraml P, Simon R, Elmenhorst K, Mirlacher M, Kononen J, Moch H (2004) Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res 64:1632–1638PubMedCrossRefGoogle Scholar
  58. Sugimoto K, Hayata T, Asashima M (2005) XBtg2 is required for notochord differentiation during early Xenopus development. Dev Growth Differ 47:435–443PubMedCrossRefGoogle Scholar
  59. Sukhatme VP, Kartha S, Toback FG, Taub R, Hoover RG, Tsai-Morris CH (1987) A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1:343–355PubMedGoogle Scholar
  60. Tirone F (2001) The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187:155–165PubMedCrossRefGoogle Scholar
  61. Varnum BC, Reddy ST, Koski RA, Herschman HR (1994) Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3. J Cell Physiol 158:205–213PubMedCrossRefGoogle Scholar
  62. Wang S, Dibenedetto AJ, Pittman RN (1997) Genes induced in programmed cell death of neuronal PC12 cells and developing sympathetic neurons in vivo. Dev Biol 188:322–336PubMedCrossRefGoogle Scholar
  63. Wang WL, Yeh SF, Chang YI, Hsiao SF, Lian WN, Lin CH, Huang CY, Lin WJ (2003) PICK1, an anchoring protein that specifically targets protein kinase Calpha to mitochondria selectively upon serum stimulation in NIH 3T3 cells. J Biol Chem 278:37705–37712PubMedCrossRefGoogle Scholar
  64. Wang Y, Shao C, Shi CH, Zhang L, Yue HH, Wang PF, Yang B, Zhang YT, Liu F, Qin WJ, Wang H, Shao GX (2005) Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Asian J Androl 7:375–380PubMedCrossRefGoogle Scholar
  65. Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H, Yamamoto T (1998) ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 16:2687–2693PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular BiologyAjou University School of MedicineSuwonKorea

Personalised recommendations